JP2024096899A5 - - Google Patents

Download PDF

Info

Publication number
JP2024096899A5
JP2024096899A5 JP2024065962A JP2024065962A JP2024096899A5 JP 2024096899 A5 JP2024096899 A5 JP 2024096899A5 JP 2024065962 A JP2024065962 A JP 2024065962A JP 2024065962 A JP2024065962 A JP 2024065962A JP 2024096899 A5 JP2024096899 A5 JP 2024096899A5
Authority
JP
Japan
Prior art keywords
cell
cells
nucleic acid
acid encoding
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024065962A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024096899A (ja
JP7817708B2 (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/027697 external-priority patent/WO2020013315A1/ja
Application filed filed Critical
Publication of JP2024096899A publication Critical patent/JP2024096899A/ja
Publication of JP2024096899A5 publication Critical patent/JP2024096899A5/ja
Priority to JP2025182692A priority Critical patent/JP2026021431A/ja
Application granted granted Critical
Publication of JP7817708B2 publication Critical patent/JP7817708B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024065962A 2018-07-13 2024-04-16 γδT細胞の製造方法 Active JP7817708B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025182692A JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2018133727 2018-07-13
JP2018133727 2018-07-13
JP2019117891 2019-06-25
JP2019117891 2019-06-25
PCT/JP2019/027697 WO2020013315A1 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法
JP2020530276A JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020530276A Division JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025182692A Division JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Publications (3)

Publication Number Publication Date
JP2024096899A JP2024096899A (ja) 2024-07-17
JP2024096899A5 true JP2024096899A5 (cg-RX-API-DMAC7.html) 2024-11-01
JP7817708B2 JP7817708B2 (ja) 2026-02-19

Family

ID=69143058

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020530276A Active JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法
JP2024065962A Active JP7817708B2 (ja) 2018-07-13 2024-04-16 γδT細胞の製造方法
JP2025182692A Pending JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020530276A Active JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025182692A Pending JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Country Status (14)

Country Link
US (4) US12391739B2 (cg-RX-API-DMAC7.html)
EP (1) EP3822342A4 (cg-RX-API-DMAC7.html)
JP (3) JP7479635B2 (cg-RX-API-DMAC7.html)
KR (1) KR102975736B1 (cg-RX-API-DMAC7.html)
CN (1) CN112513256A (cg-RX-API-DMAC7.html)
AU (1) AU2019302207B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021000437A2 (cg-RX-API-DMAC7.html)
CA (1) CA3106089A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021001064A2 (cg-RX-API-DMAC7.html)
IL (1) IL280041A (cg-RX-API-DMAC7.html)
MX (1) MX2021000459A (cg-RX-API-DMAC7.html)
SG (1) SG11202100260QA (cg-RX-API-DMAC7.html)
TW (2) TW202609051A (cg-RX-API-DMAC7.html)
WO (1) WO2020013315A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
EP3822342A4 (en) * 2018-07-13 2022-08-03 Kyoto University METHOD OF PRODUCTION OF GAMMA DELTA T-CELLS
CN109337870B (zh) 2018-12-24 2020-07-03 广东暨德康民生物科技有限责任公司 人Vγ9Vδ2T细胞扩增方法与培养基
JP7879804B2 (ja) * 2019-12-06 2026-06-24 フェイト セラピューティクス,インコーポレイテッド 小化合物を使用するiPSC由来エフェクター免疫細胞の増強
CN115885038A (zh) 2020-06-17 2023-03-31 国立大学法人京都大学 表达嵌合抗原受体的免疫活性细胞
JPWO2022059780A1 (cg-RX-API-DMAC7.html) * 2020-09-18 2022-03-24
EP4289940A4 (en) * 2021-02-05 2025-02-26 National University Corporation Kobe University ?? T-CELLS FROM INDUCED PLURIPOTENT STEM CELLS AND PRODUCTION PROCESSES THEREFOR
AU2022252997A1 (en) * 2021-04-07 2023-09-28 Century Therapeutics, Inc. Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells
CN113583955A (zh) * 2021-08-24 2021-11-02 羽铂精制生物技术(成都)有限公司 一种因子法扩增t细胞的培养基及培养方法
US20230124097A1 (en) * 2021-10-14 2023-04-20 Appia Bio, Inc. Engineering stem cell t cells with multiple t cell receptors
IL312734A (en) * 2021-11-12 2024-07-01 Janssen Biotech Inc Materials and methods for improved expansion and uses of immune cells
JPWO2023149555A1 (cg-RX-API-DMAC7.html) 2022-02-04 2023-08-10
PE20242341A1 (es) * 2022-04-04 2024-12-12 Gammadelta Therapeutics Ltd Blindaje genetico novedoso
EP4628504A3 (en) * 2022-04-04 2025-12-10 Gammadelta Therapeutics Ltd Cells expressing an anti-mesothelin car
EP4508193A4 (en) * 2022-04-11 2026-04-29 In8Bio Inc IPSC-BASED GAMMA-DELTA T LYMPHOCYTES: COMPOSITIONS AND METHODS OF USE
CN118931834B (zh) * 2024-03-07 2025-09-16 珠海善行免疫微生态产业研究院有限公司 一种人Vγ9Vδ2T细胞扩增培养基及其扩增培养方法
WO2026096605A1 (en) * 2024-10-31 2026-05-07 Pointloma Biosciences, Inc. Methods for activation and expansion of gamma delta t cells
CN119530215A (zh) * 2024-11-27 2025-02-28 珠海医米诺赛医学检验有限公司 一种血液处理液及利用该处理液进行染色体核型分析的方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937190A (en) 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
ES2336302T3 (es) 2000-04-03 2010-04-12 Therapure Biopharma Inc. Produccion de celulas ttcr gamma delta.
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
WO2006006720A1 (ja) 2004-07-13 2006-01-19 Medinet., Co.Ltd γδT細胞の培養方法、γδT細胞及び治療・予防剤
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
EP3031916B1 (en) 2007-06-11 2017-06-07 Takara Bio Inc. Method for expression of specific gene
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
WO2009032194A1 (en) 2007-08-31 2009-03-12 Whitehead Institute For Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
KR101532442B1 (ko) 2007-12-10 2015-06-29 고쿠리츠 다이가쿠 호진 교토 다이가쿠 효율적인 핵 초기화 방법
EP2242838A1 (en) 2007-12-17 2010-10-27 GliaMed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
JP5945385B2 (ja) 2008-01-16 2016-07-05 リン、シー−ランLIN, Shi−Lung 誘導性組換えrna因子を用いた腫瘍のない多能性胚性幹様細胞の生成
EP2250252A2 (en) 2008-02-11 2010-11-17 Cambridge Enterprise Limited Improved reprogramming of mammalian cells, and the cells obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
WO2009102983A2 (en) 2008-02-15 2009-08-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
JP5951254B2 (ja) 2008-03-17 2016-07-13 ザ スクリプス リサーチ インスティテュート 人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
CN102083982A (zh) 2008-04-07 2011-06-01 纽珀滕索有限公司 通过rna干扰引入复能基因而重编程细胞
CA2695590C (en) 2008-06-27 2018-01-09 Kyoto University Method of efficiently establishing induced pluripotent stem cells
JP4281071B1 (ja) 2008-07-10 2009-06-17 学校法人兵庫医科大学 Vγ9Vδ2T細胞の増殖剤、活性化Vγ9Vδ2T細胞の製造方法およびこれらの利用
WO2010009015A2 (en) 2008-07-14 2010-01-21 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/arid3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
WO2010033906A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
EP2342333A4 (en) 2008-10-30 2013-05-08 Univ Kyoto Method for producing induced pluripotent stem cells
WO2010056831A2 (en) 2008-11-12 2010-05-20 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
EP2376626A4 (en) 2008-12-13 2012-10-17 Dna Microarray MICRO-ENVIRONMENTAL NICHE ASSAY FOR SCREENING OF INDUCED PLURIPOTENT STEM CELLS (CIPS)
CA2753845C (en) 2009-02-27 2019-10-29 Kyoto University Nuclear reprogramming substance comprising glis1
US20120122212A1 (en) 2009-03-06 2012-05-17 Marica Grskovic Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
US20120076762A1 (en) 2009-03-25 2012-03-29 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
US8852940B2 (en) 2009-04-01 2014-10-07 The Regents Of The University Of California Embryonic stem cell specific microRNAs promote induced pluripotency
EP2421956A4 (en) 2009-04-24 2013-10-02 Whitehead Biomedical Inst COMPOSITIONS AND METHODS FOR OBTAINING OR CULTURING PLURIPOTENTER CELLS
CN105925535A (zh) 2009-06-05 2016-09-07 细胞动力国际有限公司 重编程t细胞和造血细胞的方法
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
US9206394B2 (en) * 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
US9834754B2 (en) 2011-11-21 2017-12-05 University Health Network Populations of hematopoietic progenitors and methods of enriching stem cells therefor
EP3789487A1 (en) * 2013-04-03 2021-03-10 Memorial Sloan Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
AU2015290554A1 (en) * 2014-07-18 2017-03-09 Kyoto University Method for inducing T cells for cell-based immunotherapy from pluripotent stem cells
EP3170895A4 (en) 2014-07-18 2018-07-11 Kawamoto, Hiroshi Production method for pluripotent stem cells having antigen-specific t cell receptor gene
CA2964785A1 (en) * 2014-11-05 2016-05-12 Board Of Regents, The University Of Texas System Gene modified immune effector cells and engineered cells for expansion of immune effector cells
US10660915B2 (en) * 2014-11-13 2020-05-26 Kyoto University Method for induction of T cells from pluripotent stem cells
GB201421716D0 (en) 2014-12-05 2015-01-21 King S College London Cell expansion procedure
US12005078B2 (en) * 2015-09-03 2024-06-11 The Uab Research Foundation Genetically engineered drug resistant T cells and methods of using the same
WO2017065288A1 (ja) * 2015-10-15 2017-04-20 国立大学法人京都大学 多能性幹細胞からcd4陽性t細胞を製造する方法
KR102929174B1 (ko) 2015-10-30 2026-02-20 더 리전츠 오브 더 유니버시티 오브 캘리포니아 줄기세포로부터 t-세포를 생산하는 방법 및 상기 t-세포를 이용한 면역치료 방법
LT3444334T (lt) * 2016-04-15 2021-12-10 Kyoto University Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas
WO2017221975A1 (ja) 2016-06-23 2017-12-28 国立大学法人京都大学 Cd4cd8両陽性t細胞の製造方法
EP3572502B1 (en) 2017-01-20 2023-01-11 Kyoto University Method for producing cd8alpha +beta + cytotoxic t cells
JP7224021B2 (ja) 2017-02-03 2023-02-17 国立大学法人神戸大学 人工多能性幹細胞の作製方法
WO2018147801A1 (en) * 2017-02-07 2018-08-16 Agency For Science, Technology And Research Methods and kits for generating mimetic innate immune cells from pluripotent stem cells
JP2018133727A (ja) 2017-02-16 2018-08-23 富士通株式会社 無線通信システム、無線通信装置、及びビームパターン決定方法
JP7171055B2 (ja) * 2017-03-14 2022-11-15 国立大学法人京都大学 多能性幹細胞からヘルパーt細胞を製造する方法
JP7109916B2 (ja) 2017-12-27 2022-08-01 株式会社ディスコ 分割装置
EP3822342A4 (en) 2018-07-13 2022-08-03 Kyoto University METHOD OF PRODUCTION OF GAMMA DELTA T-CELLS
WO2020027094A1 (ja) * 2018-07-31 2020-02-06 サイアス株式会社 iPS細胞を介して再生T細胞集団を製造する方法
AR120348A1 (es) * 2019-11-01 2022-02-09 Univ Kyoto Método para producir células t
BR112022009181A2 (pt) * 2019-11-25 2022-07-26 Univ Kyoto Sistema para prover um produto de célula t, métodos para produzir um produto de célula t, para construir um banco celular e uma coleção de produto de célula t e para prover um produto de célula t, banco celular, coleções de banco celular e de produto de célula t, e, produto de célula t
JPWO2022059780A1 (cg-RX-API-DMAC7.html) * 2020-09-18 2022-03-24
EP4219707A4 (en) * 2020-09-24 2024-11-13 Kyoto University METHOD FOR PRODUCING AN EFFECTOR CELL WITH DESIRED SPECIFICITY
EP4273234A4 (en) * 2021-01-04 2025-04-23 Thyas Co. Ltd. Method for producing a regenerated T cell via an IPS cell

Similar Documents

Publication Publication Date Title
JP2026021431A5 (cg-RX-API-DMAC7.html)
JP2021520849A5 (cg-RX-API-DMAC7.html)
JP2023055884A5 (cg-RX-API-DMAC7.html)
JP2022180510A (ja) 胎児ヘモグロビンの発現を増加させる方法
JP2022520138A5 (cg-RX-API-DMAC7.html)
JP2020511131A5 (cg-RX-API-DMAC7.html)
JP2023508740A5 (cg-RX-API-DMAC7.html)
JP2022542399A5 (cg-RX-API-DMAC7.html)
EA200700249A1 (ru) Рекомбинантное поликлональное антитело против резус-фактора d и способы его получения
JP2021528096A5 (cg-RX-API-DMAC7.html)
ATE192500T1 (de) Rekombinante viren vektoren zur expression in muskelzellen
WO2004101756A3 (en) Ovr110 antibody compositions and methods of use
JP2023504185A5 (cg-RX-API-DMAC7.html)
JP2021525519A5 (cg-RX-API-DMAC7.html)
NO20013608L (no) DNA-klon for human vevsfaktorinhibitor
JP2022522231A5 (cg-RX-API-DMAC7.html)
JP2025170345A5 (cg-RX-API-DMAC7.html)
JP2024513522A5 (cg-RX-API-DMAC7.html)
JP2021521850A5 (cg-RX-API-DMAC7.html)
JP2024511414A5 (cg-RX-API-DMAC7.html)
WO2020221291A1 (zh) 一种血红蛋白病治疗有效性预测方法
Stévenin et al. Relationship between nuclear giant-size dRNA and microsomal dRNA of rat brain
MX2024013891A (es) Vacunas y métodos para usarlas para tratar cáncer relacionado con wnt
JP2023548118A5 (cg-RX-API-DMAC7.html)
JP2022524958A5 (cg-RX-API-DMAC7.html)